Skip to content

Clinical trials

Phase 2 Respiratory Tract Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 2 Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20171
20181
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3
Completed2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
InSilico Medicine Hong Kong Limited1
Jiangsu HengRui Medicine Co., Ltd.1
Jiangsu Province Centers for Disease Control and Prevention1
Nanfang Hospital, Southern Medical University1
Pfizer1
Shanghai Public Health Clinical Center1
Sichuan Cancer Hospital and Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases7
Lung Diseases5
Bronchial Neoplasms2
Carcinoma, Bronchogenic2
Influenza, Human2
Lung Neoplasms2
Neoplasms2
Orthomyxoviridae Infections2
Respiratory Tract Infections2
Thoracic Neoplasms2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.